Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

U.S. senators ask Gilead to explain cost of Sovaldi hepatitis drug
Yahoo/Reuters
Saturday, July 12, 2014 - 10:26am
tags:
Gilead Sciences, Sovaldi
Doc Quits FDA Panel Reviewing J&J Device Over Conflict of Interest
WSJ Online
Friday, July 11, 2014 - 4:58pm
tags:
FDA, devices, J&J, Ethicon, physicians
Osiris Therapeutics' Survival In Doubt After Losing 'Pass-Through' Status In 2015
Seeking Alpha
Friday, July 11, 2014 - 12:05pm
tags:
Osiris Therapeutics, stem cells, Grafix
Shire Said to Hold Takeover Talks With AbbVie
Bloomberg
Friday, July 11, 2014 - 12:04pm
tags:
Shire, AbbVie, M&A
Sage's $60M swing is the next big test of biotech's IPO window
Fierce Biotech
Friday, July 11, 2014 - 11:21am
tags:
IPOs, biotech, SAGE Therapeutics
EMA: 39 human-use drug OKs in first-half 2014
Pharma Times, UK
Friday, July 11, 2014 - 11:17am
tags:
Europe, drug approvals
Covidien logs $180M charge over pelvic mesh lawsuits
Mass Device
Friday, July 11, 2014 - 11:15am
tags:
Covidien, pelvic mesh, devices
Gilead Faces New Pressure From U.S. Senators & Europe Over Hep C Pricing
W
Friday, July 11, 2014 - 11:13am
tags:
Gilead, hepatitis C, Sovaldi, drug pricing, Senate
If Big Pharma Ignores Antibacterial R&D, Where Will We Get The Drugs To Treat Superbugs?
Forbes
Friday, July 11, 2014 - 11:10am
tags:
R&D, antibiotics, superbugs, antibiotic resistance
How Gilead Sciences Can Deliver A Double: Part Two
Forbes
Friday, July 11, 2014 - 11:09am
tags:
Gilead, Sovaldi
As Shire stays silent, some investors urge talks with AbbVie
Yahoo/Reuters
Friday, July 11, 2014 - 11:01am
tags:
AbbVie, Shire, M&A
Nestle’s Galderma Deepens Ipsen Alliance for Wrinkle Smoother
Bloomberg
Friday, July 11, 2014 - 8:32am
tags:
Nestle, Galderma, Ipsen, Dysport, Azzalure
Questcor reports Acthar adverse effects data, NY Times says
Yahoo/Fly on the Wall
Friday, July 11, 2014 - 8:29am
tags:
adverse events, Questcor, Acthar
Dengue Vaccine Shows Promise Against 3 Out of 4 Viruses
Bloomberg
Friday, July 11, 2014 - 8:21am
tags:
dengue, vaccines, Sanofi
India's Sun Pharma recalls over 40,000 bottles of antidepressant
Yahoo/Reuters
Friday, July 11, 2014 - 8:20am
tags:
India, Sun Pharma, antidepressants, recalls
Great Deal! AbbVie Will Buy Shire and Investors Will Be Rewarded
TheStreet.com
Friday, July 11, 2014 - 8:18am
tags:
AbbVie, Shire, M&A
Astellas Seeks FDA Nod for Fungal Infection Treatment
Yahoo/Zacks.com
Thursday, July 10, 2014 - 5:50pm
tags:
Astellas, FDA, fungal infections, isavuconazole
Kythera announces FDA acceptance of ATX-101 NDA
Yahoo/Fly on the Wall
Thursday, July 10, 2014 - 5:43pm
tags:
FDA, ATX-101, Kythera, double chin
FDA Places Clinical Hold On Phase 3 Trial Of Novel Anticoagulant
Forbes
Thursday, July 10, 2014 - 3:42pm
tags:
FDA, Regado Biosciences, anticoagulants, Revolixys
Jounce Taps Merck Vet to Lead Cancer Drug Push
Motley Fool
Thursday, July 10, 2014 - 3:40pm
tags:
Jounce Therapeutics, Merck, cancer immunotherapy

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.